This disclosure relates to the treatment of bifurcated lumens with a balloon.
The body includes various passageways including blood vessels such as arteries, and other body lumens. These passageways sometimes become occluded or weakened. For example, they can be occluded by a tumor, restricted by plaque, or weakened by an aneurysm. When this occurs, the passageway can be reopened or reinforced, or even replaced, with a medical endoprosthesis. An endoprosthesis is an artificial implant that is typically placed in a passageway or lumen in the body. Many endoprostheses are tubular members, examples of which include stents, stent-grafts, and covered stents.
Many endoprostheses can be delivered inside the body by a catheter. Typically the catheter supports a reduced-size or compacted form of the endoprosthesis as it is transported to a desired site in the body, for example, the site of weakening or occlusion in a body lumen. Upon reaching the desired site, the endoprosthesis is installed so that it can contact the walls of the lumen.
One method of installation involves expanding the endoprosthesis. The expansion mechanism used to install the endoprosthesis may include forcing it to expand radially. For example, the expansion can be achieved with a catheter that carries a balloon in conjunction with a balloon-expandable endoprosthesis reduced in size relative to its final form in the body. The balloon is inflated to deform and/or expand the endoprosthesis in order to fix it at a predetermined position in contact with the lumen wall. The balloon can then be deflated, and the catheter withdrawn.
Body lumens often include bifurcated regions with branching pathways. Treatments, such as angioplasty and stent delivery, are sometimes required at locations proximate the branching physiology. A balloon configured for use with a bifurcated endoprosthesis can have a non-linear portion that expands the bifurcated portion of the endoprosthesis. It is desirable that upon deflation, the balloon forms a predictable low profile configuration that facilitates withdrawal from the body and is not likely to become caught on the endoprosthesis during removal.
The following summary is provided to facilitate an understanding of some of the innovative features unique to the present disclosure and is not intended to be a full description. A full appreciation of the disclosure can be gained by taking the entire specification, claims, drawings, and abstract as a whole.
In one embodiment, a medical device for treating a bifurcated lumen is described. The medical device may include a catheter shaft having a proximal region, a distal region, and a longitudinal axis. A main balloon may be disposed about the distal region of the catheter shaft along the longitudinal axis. A secondary balloon may be coupled to the distal region of the catheter shaft and may be disposed offset from the longitudinal axis. The secondary balloon may have an inflatable portion including a first section and a second section where the first section may be more flexible than the second section.
In another embodiment, a method of forming a medical device for treating a bifurcated lumen is described. The method may include providing a balloon system disposed about a distal region of a catheter shaft, the balloon system including a first inflatable portion along a longitudinal axis of the catheter shaft and a second inflatable portion offset from the longitudinal axis of the catheter shaft, and modifying a region of the second inflatable portion of the balloon system to form a first section and a second section in the second inflatable portion having varying crystallinity and/or thickness, wherein the first section is more flexible than the second section.
In yet another embodiment, a medical device for treating a bifurcated vessel is described. The medical device may include a catheter shaft having a proximal region and a distal region. A first balloon may be disposed about the distal region of the catheter shaft. A second balloon may be coupled to the distal region of the catheter shaft. The second balloon may include a first section and a second section forming a pattern where the first section being more flexible than the second section. The first section and the second section may cause the balloon to collapse into a predetermined configuration having one or more pleats.
The invention may be more completely understood in consideration of the following detailed description of various illustrative embodiments of the disclosure in connection with the accompanying drawings, in which:
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Referring to
The stent 14 is arranged such that it can be placed in the bifurcated region 11. In this embodiment, the stent 14 includes distal 20 and proximal 22 openings as well as a side opening 24 such that the stent 14 will not obstruct the second branch 18 when it is positioned to span the bifurcated region in the first branch 16. In addition, the stent 14 includes a main axis region 26 which is along the axis A (shown in
Referring to
Referring to
Referring to
Referring to
To modify the crystallinity of the polymer without ablation, the laser fluence is controlled such that it is below the ablation threshold. In embodiments, the same laser 30 and controller 32 can be used to form regions 114 as used for forming regions 104. The regions 114 that are treated with the lower energy have increased crystallinity, which increases the stiffness or modulus of these regions. The increased stiffness causes the treated regions to be less flexible than the unmodified regions and thus the balloon is less likely to bend in the stiffer regions than in the unmodified regions. The stiffer regions 114 form the apexes of the accordion folds upon refolding as shown in
The amount of ablation or degree of crystallinity modification can be selected to facilitate a desirable deflation profile. If the balloon is ablated, the amount of material removed can be for example, about 0.1-15%, such as 0.5 to 2.5% of the balloon wall thickness. If the balloon's crystallinity is modified without substantial ablation effects, the crystallinity of the polymer can be increased by about 2 to 90%, e.g., 2-5%, 5-10%, 10-20%, 20-40%, 40-60%, 60-70%, 70-80%, 80-90% or 20-80%, compared to the unmodified polymer. In some embodiments, the crystallinity percentage can be two, three or four times after modification than prior to modification. The thickness of the balloon in the crystallinity-modified regions and untreated regions can be substantially the same. With some materials, an increase in crystallinity is exhibited by nodules on the surface of the material. Crystallinity can be increased by heating the polymer material to between the glass transition temperature and the melt flow temperature. Within this temperature range, crystals begin to form, or crystals that were previously present grow larger. The amount of change in crystallinity can be controlled by controlling the energy delivered to the exposed regions, such as by controlling the time of exposure, the fluence and/or the wavelength of radiation. Crystallinity can be increased by increasing the exposure time at a low fluence. As noted above, the fluence threshold depends on the balloon material and on the type of wavelength of energy input into the material. Suitable UV lasers for treating the balloon have a wavelength between about 150-450 nm, such as 157, 193, 248, 308 or 351 nm. For treating a PET or a PEBAX® balloon with a 193 nm multigas laser, less than about 150 mJ/cm2, such as between about 60-70 mJ/cm2 will avoid ablating the balloon material. Other combinations of materials and lasers will have different thresholds of fluence to avoid ablation. Ultraviolet ablation is further described in U.S. Pat. No. 4,911,711. Suitable ablation and control systems are available from Coherent Lambda Physiks, in Goettingen, Germany. Crystallinity can be measured by WAX/SAX x-ray diffraction. Crystallinity measurements can be made at various vendors, such as the University of Minnesota Shepard characterization lab.
Crystallinity can be changed only on the surface or can be changed throughout the depth of the balloon wall. Suitable techniques for inputting heat into the balloon, such as UV lasers, affect primarily the surface of the balloon. For example, a UV laser may penetrate only part way into a polymer surface, such as 1-60 Angstroms into the balloon. Other heating techniques can penetrate more deeply into the material. With some methods of applying energy, the energy not only penetrates into the material, but radiates isotropically. This heating is considered to be massive or bulk heating of the material, because more than just the surface of the material is heated. A laser, such as a CO2 laser, an IR laser, a YAG laser, a diode laser, excimer laser, or any another suitable photon source, or a heat stick, i.e., a conductive material connected to a heat cartridge, or an RF generator can be used to apply heat to the balloon. In the case of an RF generator, a jelly having metal particles can be applied to the regions to be treated. If a laser is used to apply heat to the balloon, the balloon can be filled with a fluid to absorb the heat and prevent other portions of the balloon from being simultaneously treated. As noted herein, the amount of crystallinity can be controlled, such as by controlling the amount of time that energy is input into the balloon or controlling the energy output by the energy input device. To focus the heat on particular regions of the balloon, a mask can be used or the device for applying the heat can be focused only in the region where crystallization is desired. With some methods of treating the balloon, the depth of the crystallization can determine whether the treated region ends up on the apex or the valley of a fold. Surface treatment with a UV laser tends to form treated regions that are in the valleys of the folds of the balloon, where treatment with a CO2 laser or hot stick forms treated regions that are on the apex of the folds a balloon.
Flexibility or stiffness variations can also be created by other techniques, such as ion beam exposure and mechanically by cutting regions of the balloon wall. All of these techniques can be used in any combination to provide desired properties to the balloon. Ion beam treatment is further described in U.S. application Ser. No. 11/533,588, filed Sep. 20, 2006, and U.S. application Ser. No. 11/355,392, filed Feb. 16, 2006, both of which are incorporated herein by reference in their entirety. The treated regions can be formed by application of energy on the balloon directly or on a polymer tubular parison that is subsequently formed or blown into a balloon, e.g. by free inflation or blow molding. Balloon formation is described further in U.S. Pat. No. 4,963,313.
Referring to
Polymers suitable for forming the balloon include biaxially oriented polymers, thermoplastic elastomers, engineering thermoplastic elastomers, polyethylenes, polyethylene terephthalate (PET), polybutylenes, polyamides (e.g. nylon 66), polyether block amides (e.g., PEBAX®), polypropylene (PP), polystyrene (PS), polyvinyl chlorides (PVC), polytetrafluorethylene (PTFE), polymethylmethacrylate (PMMA), polyimide, polycarbonate (PC), polyisoprene rubber (PI), nitrile rubbers, silicone rubbers, ethylene-propylene diene rubbers (EPDM), butyl rubbers (BR), ethyl-ester thermoplastic elastomers (e.g., ARNITEL®), thermoplastic polyurethanes (PU) (e.g., those based on a glycol ether and an isocyanate, such as PELLETHANE®). In particular embodiments, a poly(ether-amide) block copolymer having the general formula
in which PA represents a polyamide segment, e.g., nylon 12, and PE represents a polyether segment, e.g., poly(tetramethylene glycol) is utilized. Such polymers are commercially available from ARKEMA under the tradename PEBAX®. The balloon can be formed of single polymer or of multiple polymers, e.g. by coextrusion.
In addition to the linear treated regions described, the treated regions can be arranged in other configurations to enhance refolding. In some embodiments, the treated regions spiral around the dome of the balloon, so that the spiral winds around an axis that is perpendicular to the axis along which the sleeves extend. The spiral region can be one continuous region or can be series of non-contiguous regions that generally are in a spiral pattern. Referring to
Referring to
Treating selected portions of a bifurcated balloon cause a bifurcation balloon to collapse in a predictable way when the balloon is deflated. The collapsed state can be selected so that the balloon folds in a compact manner. The more compact the balloon is when collapsed, the easier it may be to remove the balloon from a lumen after the balloon inflation and deflation. Moreover, a more compactly folded balloon may be less likely to catch on an expanded stent upon removal. Unlike cylindrical balloons, the bifurcation balloons tend to be in a naturally expanded state, even when they are not inflated. Thus, treating the balloons to enhance folding can add particular folding characteristics that the balloon would not otherwise have.
A 2.0×2.75 mm bifurcation PEBAX® polymer balloon made by Boston Scientific, Natick, Mass., is exposed to UV radiation using a Lambda LPX210i, multigas UV excimer laser (available from Coherent Lambda Physiks, in Goettingen, Germany) using an argon fluoride gas mixture operating at a pulse duration of 29 ns, a repetition rate of 25 Hz and at a wavelength of 193 nm with an attenuator set at 100% VA to deliver a fluence of 100 mJ/cm2, which is above the ablation threshold of PEBAX®, which is around 60-70 mJ/cm2. The homogenized beam from the laser is about 9 mm wide and about 9 mm long. Five parallel linear regions approximately 0.14 mm in width spaced equidistantly up the side of the dome of the balloon are exposed through a mask. Three of the regions are exposed at a shot spacing of 75 microns. Two of the regions are exposed at a shot spacing of 100 microns. The exposed regions became opaque.
Embodiments may include one or more of the following advantages. Balloon treatment of bifurcated lumens can be facilitated by reducing the likelihood that the balloon fold into a predictable configuration upon deflation. The profile of the side branch balloon on deflation after angioplasty or stent delivery can be reduced, e.g. by folding or forming into a desired, predictable configuration that facilitates withdrawal from a body lumen. It can require less withdrawal force to remove a balloon that has been folded compactly from a lumen than to remove a similar balloon that has not been folded compactly from the same lumen.
A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims priority to U.S. Provisional Application No. 61/059,243 filed on Jun. 5, 2008, the entire contents of which is hereby incorporated by reference. This application is related to U.S. application Ser. No. 11/599,049, filed Nov. 14, 2007, and U.S. application Ser. No. 12/479,611 filed on even date herewith, which claims the benefit of U.S. Provisional Application Ser. No. 61/059,250 field Jun. 5, 2008, the entire contents of all of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1596754 | Moschelle | Aug 1926 | A |
3657744 | Ersek | Apr 1972 | A |
3872893 | Roberts | Mar 1975 | A |
4140126 | Choudhury | Feb 1979 | A |
4309994 | Grunwald | Jan 1982 | A |
4410476 | Redding et al. | Oct 1983 | A |
4413989 | Schjeldahl et al. | Nov 1983 | A |
4421810 | Rasmussen | Dec 1983 | A |
4453545 | Inoue | Jun 1984 | A |
4479497 | Fogarty et al. | Oct 1984 | A |
4503569 | Dotter | Mar 1985 | A |
4552554 | Gould et al. | Nov 1985 | A |
4681570 | Dalton | Jul 1987 | A |
4689174 | Lupke | Aug 1987 | A |
4731055 | Melinyshyn et al. | Mar 1988 | A |
4733665 | Palmaz | Mar 1988 | A |
4739662 | Foote | Apr 1988 | A |
4759748 | Reed | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4769029 | Patel | Sep 1988 | A |
4819664 | Nazari | Apr 1989 | A |
4872874 | Taheri | Oct 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4896670 | Crittenden | Jan 1990 | A |
4900314 | Quackenbush | Feb 1990 | A |
4906244 | Pinchuk et al. | Mar 1990 | A |
4909258 | Kuntz et al. | Mar 1990 | A |
4911711 | Telfair et al. | Mar 1990 | A |
4941877 | Montano, Jr. | Jul 1990 | A |
4946464 | Pevsner | Aug 1990 | A |
4957501 | Lahille et al. | Sep 1990 | A |
4957508 | Kaneko et al. | Sep 1990 | A |
4963313 | Noddin et al. | Oct 1990 | A |
4964850 | Bouton et al. | Oct 1990 | A |
4983167 | Sahota | Jan 1991 | A |
4994071 | MacGregor | Feb 1991 | A |
5042976 | Ishitsu et al. | Aug 1991 | A |
5054501 | Chuttani et al. | Oct 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5061240 | Cherian | Oct 1991 | A |
5064435 | Porter | Nov 1991 | A |
5085664 | Bozzo | Feb 1992 | A |
5102403 | Alt | Apr 1992 | A |
5102417 | Palmaz | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5117831 | Jang et al. | Jun 1992 | A |
5122125 | Deuss | Jun 1992 | A |
5135536 | Hillstead | Aug 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5147385 | Beck et al. | Sep 1992 | A |
5156785 | Zdrahala | Oct 1992 | A |
5159920 | Condon et al. | Nov 1992 | A |
5192297 | Hull | Mar 1993 | A |
5195970 | Gahara | Mar 1993 | A |
5195984 | Schatz | Mar 1993 | A |
5211683 | Maginot | May 1993 | A |
5217440 | Frassica | Jun 1993 | A |
5222971 | Willard et al. | Jun 1993 | A |
5226913 | Pinchuk | Jul 1993 | A |
5234457 | Andersen | Aug 1993 | A |
5236446 | Dumon | Aug 1993 | A |
5257974 | Cox | Nov 1993 | A |
5263932 | Jang | Nov 1993 | A |
5304220 | Maginot | Apr 1994 | A |
5306246 | Sahatjian et al. | Apr 1994 | A |
5320605 | Sahota | Jun 1994 | A |
5324257 | Osborne et al. | Jun 1994 | A |
5334153 | McIntyre et al. | Aug 1994 | A |
5337733 | Bauerfeind et al. | Aug 1994 | A |
5338300 | Cox | Aug 1994 | A |
5342295 | Imran | Aug 1994 | A |
5342297 | Jang | Aug 1994 | A |
5342387 | Summers | Aug 1994 | A |
5350395 | Yock | Sep 1994 | A |
5382472 | Yanidis et al. | Jan 1995 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5387235 | Chuter | Feb 1995 | A |
5395332 | Resseman et al. | Mar 1995 | A |
5395334 | Keith et al. | Mar 1995 | A |
5404887 | Prather | Apr 1995 | A |
5409458 | Khairkhahan et al. | Apr 1995 | A |
5413581 | Goy | May 1995 | A |
5413586 | Dibie et al. | May 1995 | A |
5417208 | Winkler | May 1995 | A |
5425765 | Tiefenbrun et al. | Jun 1995 | A |
5437638 | Bowman | Aug 1995 | A |
5443497 | Venbrux | Aug 1995 | A |
5445624 | Jimenez | Aug 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5449382 | Dayton | Sep 1995 | A |
5456666 | Campbell et al. | Oct 1995 | A |
5456694 | Marin et al. | Oct 1995 | A |
5456712 | Maginot | Oct 1995 | A |
5456714 | Owen | Oct 1995 | A |
5458572 | Campbell et al. | Oct 1995 | A |
5458605 | Klemm | Oct 1995 | A |
5462530 | Jang | Oct 1995 | A |
5476471 | Shifrin et al. | Dec 1995 | A |
5489271 | Andersen | Feb 1996 | A |
5489295 | Piplani et al. | Feb 1996 | A |
5496292 | Burnham | Mar 1996 | A |
5505702 | Arney | Apr 1996 | A |
5507768 | Lau et al. | Apr 1996 | A |
5507769 | Marin et al. | Apr 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5514178 | Torchio | May 1996 | A |
5522801 | Wang | Jun 1996 | A |
5531788 | Dibie et al. | Jul 1996 | A |
5545132 | Fagan et al. | Aug 1996 | A |
5549553 | Ressemann et al. | Aug 1996 | A |
5549554 | Miraki | Aug 1996 | A |
5562620 | Klein et al. | Oct 1996 | A |
5562724 | Vorwerk et al. | Oct 1996 | A |
5562725 | Schmitt et al. | Oct 1996 | A |
5562726 | Chuter | Oct 1996 | A |
5569295 | Lam | Oct 1996 | A |
5571087 | Ressemann et al. | Nov 1996 | A |
5575771 | Walinsky | Nov 1996 | A |
5575817 | Martin | Nov 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5591228 | Edoga | Jan 1997 | A |
5593442 | Klein | Jan 1997 | A |
5607444 | Lam | Mar 1997 | A |
5609605 | Marshall et al. | Mar 1997 | A |
5609625 | Piplani et al. | Mar 1997 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5609629 | Fearnot et al. | Mar 1997 | A |
5613949 | Miraki | Mar 1997 | A |
5613980 | Chauhan | Mar 1997 | A |
5613981 | Boyle et al. | Mar 1997 | A |
5617878 | Taheri | Apr 1997 | A |
5626600 | Horzewski et al. | May 1997 | A |
5628788 | Pinchuk | May 1997 | A |
5632762 | Myler | May 1997 | A |
5632763 | Glastra | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5634902 | Johnson et al. | Jun 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5643340 | Nunokawa | Jul 1997 | A |
5653743 | Martin | Aug 1997 | A |
5662614 | Edoga | Sep 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5669932 | Fischell et al. | Sep 1997 | A |
5674197 | van Muiden et al. | Oct 1997 | A |
5676696 | Marcade | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5679400 | Tuch | Oct 1997 | A |
5683451 | Lenker et al. | Nov 1997 | A |
5690642 | Osborne et al. | Nov 1997 | A |
5693084 | Chuter | Dec 1997 | A |
5693086 | Goicoechea et al. | Dec 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5707354 | Salmon et al. | Jan 1998 | A |
5709713 | Evans et al. | Jan 1998 | A |
5716365 | Goicoechea et al. | Feb 1998 | A |
5716617 | Khandke et al. | Feb 1998 | A |
5718683 | Ressemann et al. | Feb 1998 | A |
5718724 | Goicoechea et al. | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5723004 | Dereume et al. | Mar 1998 | A |
5724977 | Yock et al. | Mar 1998 | A |
5728158 | Lau et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5735893 | Lau et al. | Apr 1998 | A |
5746766 | Edoga | May 1998 | A |
5749825 | Fischell et al. | May 1998 | A |
5749848 | Jang et al. | May 1998 | A |
5755734 | Richter et al. | May 1998 | A |
5755735 | Richter et al. | May 1998 | A |
5755770 | Ravenscroft | May 1998 | A |
5755771 | Penn et al. | May 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5759172 | Weber et al. | Jun 1998 | A |
5762631 | Klein | Jun 1998 | A |
5776101 | Goy | Jul 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5776180 | Goicoechea et al. | Jul 1998 | A |
5782906 | Marshall et al. | Jul 1998 | A |
5797947 | Mollenauer | Aug 1998 | A |
5800450 | Lary et al. | Sep 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5814061 | Osborne et al. | Sep 1998 | A |
5817126 | Imran | Oct 1998 | A |
5824008 | Bolduc et al. | Oct 1998 | A |
5824036 | Lauterjung | Oct 1998 | A |
5824040 | Cox et al. | Oct 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
5824044 | Quiachon et al. | Oct 1998 | A |
5827320 | Richter et al. | Oct 1998 | A |
5833650 | Imran | Nov 1998 | A |
5836966 | St. Germain | Nov 1998 | A |
5837008 | Berg et al. | Nov 1998 | A |
5838856 | Lee | Nov 1998 | A |
5843031 | Hermann et al. | Dec 1998 | A |
5843160 | Rhodes | Dec 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5846204 | Solomon | Dec 1998 | A |
5851210 | Torossian | Dec 1998 | A |
5851464 | Davila et al. | Dec 1998 | A |
5853389 | Hijlkema | Dec 1998 | A |
5855600 | Alt | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5865178 | Yock | Feb 1999 | A |
5868777 | Lam | Feb 1999 | A |
5871536 | Lazarus | Feb 1999 | A |
5871537 | Holman et al. | Feb 1999 | A |
5891133 | Murphy-Chutorian | Apr 1999 | A |
5897588 | Hull et al. | Apr 1999 | A |
5906640 | Penn et al. | May 1999 | A |
5907893 | Zadno-Azizi et al. | Jun 1999 | A |
5913895 | Burpee et al. | Jun 1999 | A |
5913897 | Corso, Jr. et al. | Jun 1999 | A |
5921958 | Ressemann et al. | Jul 1999 | A |
5922020 | Klein et al. | Jul 1999 | A |
5928248 | Acker | Jul 1999 | A |
5938682 | Hojeibane et al. | Aug 1999 | A |
5938696 | Goicoecchea et al. | Aug 1999 | A |
5948016 | Jang | Sep 1999 | A |
5951599 | McCrory | Sep 1999 | A |
5961548 | Shmulewitz | Oct 1999 | A |
5967986 | Cimochowski et al. | Oct 1999 | A |
5972018 | Israel et al. | Oct 1999 | A |
6007517 | Anderson | Dec 1999 | A |
6013054 | Jiun Yan | Jan 2000 | A |
6013091 | Ley et al. | Jan 2000 | A |
6017324 | Tu et al. | Jan 2000 | A |
6017363 | Hojeibane | Jan 2000 | A |
6024763 | Lenker et al. | Feb 2000 | A |
6030414 | Taheri | Feb 2000 | A |
6033434 | Borghi | Mar 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6036682 | Lange et al. | Mar 2000 | A |
6039749 | Marin et al. | Mar 2000 | A |
6042597 | Kveen et al. | Mar 2000 | A |
6045557 | White et al. | Apr 2000 | A |
6048361 | Von Oepen | Apr 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6059823 | Holman et al. | May 2000 | A |
6059824 | Taheri | May 2000 | A |
6066168 | Lau et al. | May 2000 | A |
6068655 | Seguin et al. | May 2000 | A |
6071285 | Lashinski et al. | Jun 2000 | A |
6086611 | Duffy et al. | Jul 2000 | A |
6090127 | Globerman | Jul 2000 | A |
6090128 | Douglas | Jul 2000 | A |
6090133 | Richter et al. | Jul 2000 | A |
6096073 | Webster et al. | Aug 2000 | A |
6099497 | Adams et al. | Aug 2000 | A |
6117117 | Mauch | Sep 2000 | A |
6117156 | Richter et al. | Sep 2000 | A |
6126685 | Lenker et al. | Oct 2000 | A |
6129738 | Lashinski et al. | Oct 2000 | A |
6129754 | Kanesaka et al. | Oct 2000 | A |
6142973 | Carleton et al. | Nov 2000 | A |
6152945 | Bachinski et al. | Nov 2000 | A |
6165195 | Wilson et al. | Dec 2000 | A |
6165197 | Yock | Dec 2000 | A |
6165214 | Lazarus | Dec 2000 | A |
6179867 | Cox | Jan 2001 | B1 |
6183506 | Penn et al. | Feb 2001 | B1 |
6183509 | Dibie | Feb 2001 | B1 |
6190403 | Fischell et al. | Feb 2001 | B1 |
6193746 | Strecker | Feb 2001 | B1 |
6203569 | Wijay | Mar 2001 | B1 |
6210380 | Mauch | Apr 2001 | B1 |
6210429 | Vardi et al. | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6217608 | Penn et al. | Apr 2001 | B1 |
6221080 | Power | Apr 2001 | B1 |
6221090 | Wilson | Apr 2001 | B1 |
6221098 | Wilson et al. | Apr 2001 | B1 |
6231563 | White et al. | May 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6231600 | Zhong | May 2001 | B1 |
6235051 | Murphy | May 2001 | B1 |
6241762 | Shanley | Jun 2001 | B1 |
6258073 | Mauch | Jul 2001 | B1 |
6258099 | Mariero et al. | Jul 2001 | B1 |
6258116 | Hojeibane | Jul 2001 | B1 |
6258121 | Yang et al. | Jul 2001 | B1 |
6261273 | Ruiz | Jul 2001 | B1 |
6261305 | Marotta et al. | Jul 2001 | B1 |
6261319 | Kveen et al. | Jul 2001 | B1 |
6264682 | Wilson et al. | Jul 2001 | B1 |
6273911 | Cox et al. | Aug 2001 | B1 |
6273913 | Wright et al. | Aug 2001 | B1 |
6287314 | Lee et al. | Sep 2001 | B1 |
6290673 | Shanley | Sep 2001 | B1 |
6293967 | Shanley | Sep 2001 | B1 |
6299634 | Bergeron | Oct 2001 | B1 |
6302906 | Goicoecchea et al. | Oct 2001 | B1 |
6309412 | Lau et al. | Oct 2001 | B1 |
6309414 | Rolando et al. | Oct 2001 | B1 |
6312459 | Huang et al. | Nov 2001 | B1 |
6325821 | Gaschino et al. | Dec 2001 | B1 |
6325826 | Vardi et al. | Dec 2001 | B1 |
6334870 | Ehr et al. | Jan 2002 | B1 |
6346089 | Dibie | Feb 2002 | B1 |
6350278 | Lenker et al. | Feb 2002 | B1 |
6355060 | Lenker et al. | Mar 2002 | B1 |
6358266 | Bonutti | Mar 2002 | B1 |
6361544 | Wilson et al. | Mar 2002 | B1 |
6361555 | Wilson | Mar 2002 | B1 |
6371978 | Wilson | Apr 2002 | B1 |
6383213 | Wilson et al. | May 2002 | B2 |
6383215 | Sass | May 2002 | B1 |
6387120 | Wilson et al. | May 2002 | B2 |
6395018 | Castaneda | May 2002 | B1 |
6398792 | O'Connor | Jun 2002 | B1 |
6398804 | Spielberg | Jun 2002 | B1 |
6428567 | Wilson et al. | Aug 2002 | B2 |
6428568 | Gaudoin et al. | Aug 2002 | B2 |
6428570 | Globerman | Aug 2002 | B1 |
6432133 | Lau et al. | Aug 2002 | B1 |
6436104 | Hojeibane | Aug 2002 | B2 |
6436134 | Richter et al. | Aug 2002 | B2 |
6468302 | Cox et al. | Oct 2002 | B2 |
6475208 | Mauch | Nov 2002 | B2 |
6478816 | Kveen et al. | Nov 2002 | B1 |
6482211 | Choi | Nov 2002 | B1 |
6485511 | Lau et al. | Nov 2002 | B2 |
6494905 | Zedler et al. | Dec 2002 | B1 |
6508836 | Wilson et al. | Jan 2003 | B2 |
6511504 | Lau et al. | Jan 2003 | B1 |
6511505 | Cox et al. | Jan 2003 | B2 |
6520988 | Colombo et al. | Feb 2003 | B1 |
6527799 | Shanley | Mar 2003 | B2 |
6540719 | Bigus et al. | Apr 2003 | B2 |
6540779 | Richter et al. | Apr 2003 | B2 |
6572647 | Supper et al. | Jun 2003 | B1 |
6579309 | Loos et al. | Jun 2003 | B1 |
6579312 | Wilson et al. | Jun 2003 | B2 |
6582394 | Reiss et al. | Jun 2003 | B1 |
6582459 | Lau et al. | Jun 2003 | B1 |
6596020 | Vardi et al. | Jul 2003 | B2 |
6596022 | Lau et al. | Jul 2003 | B2 |
6599315 | Wilson | Jul 2003 | B2 |
6599316 | Vardi et al. | Jul 2003 | B2 |
6602284 | Cox et al. | Aug 2003 | B2 |
6641609 | Globerman | Nov 2003 | B2 |
6645241 | Strecker | Nov 2003 | B1 |
6652573 | Von Oepen | Nov 2003 | B2 |
6669717 | Marotta et al. | Dec 2003 | B2 |
6676667 | Mariero et al. | Jan 2004 | B2 |
6679911 | Burgermeister | Jan 2004 | B2 |
6689156 | Davidson et al. | Feb 2004 | B1 |
6692483 | Vardi et al. | Feb 2004 | B2 |
6695877 | Brucker et al. | Feb 2004 | B2 |
6706062 | Vardi et al. | Mar 2004 | B2 |
6709440 | Callol et al. | Mar 2004 | B2 |
6736841 | Musbach et al. | May 2004 | B2 |
6770092 | Richter | Aug 2004 | B2 |
6780174 | Mauch | Aug 2004 | B2 |
6802856 | Wilson | Oct 2004 | B2 |
6827735 | Greenberg | Dec 2004 | B2 |
6827736 | Perouse | Dec 2004 | B2 |
6835203 | Vardi et al. | Dec 2004 | B1 |
6852124 | Cox et al. | Feb 2005 | B2 |
6855125 | Shanley | Feb 2005 | B2 |
6890349 | McGukin, Jr. et al. | May 2005 | B2 |
6908477 | McGukin, Jr. et al. | Jun 2005 | B2 |
6942689 | Majercak | Sep 2005 | B2 |
6962602 | Vardi et al. | Nov 2005 | B2 |
6989025 | Burgmeier et al. | Jan 2006 | B2 |
7004963 | Wang et al. | Feb 2006 | B2 |
7056323 | Mariero et al. | Jun 2006 | B2 |
7105019 | Hojeibane | Sep 2006 | B2 |
7118593 | Davidson et al. | Oct 2006 | B2 |
7125419 | Sequin et al. | Oct 2006 | B2 |
7163553 | Limon | Jan 2007 | B2 |
7220275 | Davidson et al. | May 2007 | B2 |
7238197 | Sequin et al. | Jul 2007 | B2 |
7244853 | Schreiber et al. | Jul 2007 | B2 |
7252679 | Fischell et al. | Aug 2007 | B2 |
7344557 | Yadin | Mar 2008 | B2 |
7387639 | Bourang et al. | Jun 2008 | B2 |
7585317 | Davidson et al. | Sep 2009 | B2 |
20010012927 | Mauch | Aug 2001 | A1 |
20010016767 | Wilson et al. | Aug 2001 | A1 |
20010016768 | Wilson et al. | Aug 2001 | A1 |
20010027291 | Shanley | Oct 2001 | A1 |
20010027338 | Greenberg | Oct 2001 | A1 |
20010029396 | Wilson et al. | Oct 2001 | A1 |
20010037116 | Wilson et al. | Nov 2001 | A1 |
20010037138 | Wilson et al. | Nov 2001 | A1 |
20010037140 | Gaudoin et al. | Nov 2001 | A1 |
20010037146 | Lau et al. | Nov 2001 | A1 |
20010037147 | Lau et al. | Nov 2001 | A1 |
20010039395 | Mariero et al. | Nov 2001 | A1 |
20010039448 | Dibie | Nov 2001 | A1 |
20010041927 | Solem | Nov 2001 | A1 |
20010047201 | Cox et al. | Nov 2001 | A1 |
20010049552 | Richter et al. | Dec 2001 | A1 |
20010056297 | Hojeibane | Dec 2001 | A1 |
20020013618 | Marotta et al. | Jan 2002 | A1 |
20020013619 | Shanley | Jan 2002 | A1 |
20020022874 | Wilson | Feb 2002 | A1 |
20020026232 | Marotta et al. | Feb 2002 | A1 |
20020032478 | Boekstegers et al. | Mar 2002 | A1 |
20020035392 | Wilson | Mar 2002 | A1 |
20020042650 | Vardi et al. | Apr 2002 | A1 |
20020052648 | McGukin, Jr. et al. | May 2002 | A1 |
20020058990 | Jang | May 2002 | A1 |
20020072790 | McGuckin, Jr. et al. | Jun 2002 | A1 |
20020107564 | Cox et al. | Aug 2002 | A1 |
20020111675 | Wilson | Aug 2002 | A1 |
20020123790 | White et al. | Sep 2002 | A1 |
20020123797 | Majercak | Sep 2002 | A1 |
20020123798 | Burgermeister | Sep 2002 | A1 |
20020151959 | Von Oepen | Oct 2002 | A1 |
20020156516 | Vardi et al. | Oct 2002 | A1 |
20020156517 | Perouse | Oct 2002 | A1 |
20020165604 | Shanley | Nov 2002 | A1 |
20020173835 | Bourang et al. | Nov 2002 | A1 |
20020173840 | Brucker et al. | Nov 2002 | A1 |
20020177892 | Globerman | Nov 2002 | A1 |
20020183763 | Callol et al. | Dec 2002 | A1 |
20020193872 | Trout, III et al. | Dec 2002 | A1 |
20020193873 | Brucker et al. | Dec 2002 | A1 |
20030004535 | Musbach et al. | Jan 2003 | A1 |
20030009209 | Hojeibane | Jan 2003 | A1 |
20030009214 | Shanley | Jan 2003 | A1 |
20030014102 | Hong et al. | Jan 2003 | A1 |
20030023301 | Cox et al. | Jan 2003 | A1 |
20030028211 | Crocker et al. | Feb 2003 | A1 |
20030050688 | Fischell et al. | Mar 2003 | A1 |
20030055378 | Wang et al. | Mar 2003 | A1 |
20030074047 | Richter | Apr 2003 | A1 |
20030093109 | Mauch | May 2003 | A1 |
20030114912 | Sequin et al. | Jun 2003 | A1 |
20030114915 | Mariero et al. | Jun 2003 | A1 |
20030125791 | Sequin et al. | Jul 2003 | A1 |
20030125799 | Limon | Jul 2003 | A1 |
20030125802 | Callol et al. | Jul 2003 | A1 |
20030144683 | Sirhan et al. | Jul 2003 | A1 |
20030163148 | Wang et al. | Aug 2003 | A1 |
20040015227 | Vardi et al. | Jan 2004 | A1 |
20040072849 | Schreiber et al. | Apr 2004 | A1 |
20040117003 | Ouriel et al. | Jun 2004 | A1 |
20040133223 | Weber | Jul 2004 | A1 |
20040133268 | Davidson et al. | Jul 2004 | A1 |
20040138737 | Davidson et al. | Jul 2004 | A1 |
20040148006 | Davidson et al. | Jul 2004 | A1 |
20040225318 | Eidenschink et al. | Nov 2004 | A1 |
20050015046 | Weber et al. | Jan 2005 | A1 |
20050015108 | Williams et al. | Jan 2005 | A1 |
20050027344 | Eidenschink | Feb 2005 | A1 |
20050060027 | Khenansho et al. | Mar 2005 | A1 |
20050102019 | Yadin | May 2005 | A1 |
20050102023 | Yadin et al. | May 2005 | A1 |
20050177130 | Konstantino et al. | Aug 2005 | A1 |
20060182873 | Klisch et al. | Aug 2006 | A1 |
20070067018 | Miller | Mar 2007 | A1 |
20070191923 | Weber et al. | Aug 2007 | A1 |
20080097302 | Chen | Apr 2008 | A1 |
20080109060 | Yadin | May 2008 | A1 |
20080114294 | Holman et al. | May 2008 | A1 |
20080125706 | Sutermeister et al. | May 2008 | A1 |
20080243221 | Arcand | Oct 2008 | A1 |
Number | Date | Country |
---|---|---|
2318314 | Jul 1999 | CA |
9014845.2 | Jan 1991 | DE |
29701758 | Mar 1997 | DE |
0551179 | Jul 1993 | EP |
0646365 | Apr 1995 | EP |
0684022 | Nov 1995 | EP |
0804907 | Nov 1997 | EP |
0876805 | Nov 1998 | EP |
0884028 | Dec 1998 | EP |
0891751 | Jan 1999 | EP |
0897698 | Feb 1999 | EP |
0897700 | Feb 1999 | EP |
0904745 | Mar 1999 | EP |
1031328 | Aug 2000 | EP |
1031330 | Aug 2000 | EP |
1157674 | Nov 2001 | EP |
1254644 | Nov 2002 | EP |
2678508 | Jan 1993 | FR |
WO 8806026 | Aug 1988 | WO |
WO 9013332 | Nov 1990 | WO |
WO 9112779 | Sep 1991 | WO |
WO 9219308 | Nov 1992 | WO |
WO 9426180 | Nov 1994 | WO |
WO 9508965 | Apr 1995 | WO |
WO 9521592 | Aug 1995 | WO |
WO 9629955 | Oct 1996 | WO |
WO 9641592 | Dec 1996 | WO |
WO 9709946 | Mar 1997 | WO |
WO 9716217 | May 1997 | WO |
WO 9726936 | Jul 1997 | WO |
WO 9732544 | Sep 1997 | WO |
WO 9733532 | Sep 1997 | WO |
WO 9741803 | Nov 1997 | WO |
WO 9745073 | Dec 1997 | WO |
WO 9817204 | Apr 1998 | WO |
WO 9819628 | May 1998 | WO |
WO 9835634 | Aug 1998 | WO |
WO 9836709 | Aug 1998 | WO |
WO 9837833 | Sep 1998 | WO |
WO 9844871 | Oct 1998 | WO |
WO 9848733 | Nov 1998 | WO |
WO 9852497 | Nov 1998 | WO |
WO 9915103 | Apr 1999 | WO |
WO 9917680 | Apr 1999 | WO |
WO 9924104 | May 1999 | WO |
WO 9934749 | Jul 1999 | WO |
WO 9936002 | Jul 1999 | WO |
WO 9939661 | Aug 1999 | WO |
WO 9958059 | Nov 1999 | WO |
WO 9965419 | Dec 1999 | WO |
WO 0000104 | Jan 2000 | WO |
WO 0012166 | Mar 2000 | WO |
WO 0013613 | Mar 2000 | WO |
WO 0053122 | Sep 2000 | WO |
WO 0074595 | Dec 2000 | WO |
WO 0121095 | Mar 2001 | WO |
WO 0121109 | Mar 2001 | WO |
WO 0121244 | Mar 2001 | WO |
WO 0170299 | Sep 2001 | WO |
WO 02068012 | Sep 2002 | WO |
WO 02076333 | Oct 2002 | WO |
WO 02094336 | Nov 2002 | WO |
WO 03055414 | Jul 2003 | WO |
WO 2004026180 | Apr 2004 | WO |
WO 2005046757 | May 2005 | WO |
WO 2005122958 | Dec 2005 | WO |
2006014631 | Feb 2006 | WO |
WO 2006053106 | May 2006 | WO |
2008024220 | Feb 2008 | WO |
Entry |
---|
U.S. Appl. No. 12/479,611 to Richard A. Noddin et al., filed Jun. 5, 2009. |
Caputo et al., “Stent Jail: A Minimum-Security Prison,” The American Journal of Cardiology, vol. 77, pp. 1226-1230, Jun. 1, 1996. |
Carrie et al., “‘T’-Shaped Stent Placement: A Technique for the Treatment of Dissected Bifurcation Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 37, pp. 311-313, 1996. |
Chevalier et at., “Placement of Coronary Stents in Bifurcation Lesions by the ‘Culotte’ Technique,” The American Journal of Cardiology, vol. 82, pp. 943-949, Oct. 15, 1998. |
Colombo et al., “‘Kissing’ Stents for Bifurcational Coronary Lesion,” Catheterization and Cardiovascular Diagnosis, vol. 30, pp. 327-330, 1993. |
Dichek et al., “Seeding of Intravascular Stents with Genetically Engineered Endothelial Cells,” Circulation,vol. 80, No. 5, pp. 1347-1353, Nov. 1989. |
Fischman et al., “A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease,” New England Journal of Medicine, vol. 331, No. 8, pp. 496-501, Aug. 25, 1994. |
Katoh et al., “New Double Wire Technique to Stent Ostial Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 40, pp. 400-402, 1997. |
“Laser”, Wikipedia, the free encyclopedia, http://en.wikipedia.org./wiki/Laser, printed Mar. 21, 2006, 11 pages. |
Lewis et al., “Acute Procedural Results in the Treatment of 30 Coronary Artery Bifurcation Lesions with a Double-Wire Atherectomy Technique for Side-Branch Protection,” American Heart Journal, vol. 127, No. 6, pp. 1600-1607, 1994. |
Nakamura et al., “Techniques for Palmaz-Schatz Stent Deployment in Lesions with a Large Side Branch,” Catheterization and Cardiovascular Diagnosis, vol. 34, pp. 353-361, 1995. |
Satler et al. “Bifurcation Disease: To Treat or Not to Treat,” Catheterization and Cardiovascular Interventions, vol. 50, pp. 411-412, 2000. |
Serruys et al., “A Comparison of Balloon Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease,” The New England Journal of Medicine, vol. 331, No. 8, pp. 489-495, Aug. 25, 1994. |
Yamashita et al., “Bifurcation Lesions: Two Stents Versus One Stent—Immediate and Follow-up Results,” Journal of the American College of Cardiology, vol. 35, No. 5, pp. 1145-1151, Apr. 2000. |
Number | Date | Country | |
---|---|---|---|
20100114019 A1 | May 2010 | US |
Number | Date | Country | |
---|---|---|---|
61059243 | Jun 2008 | US |